Copyright
©The Author(s) 2003.
World J Gastroenterol. May 15, 2003; 9(5): 1003-1007
Published online May 15, 2003. doi: 10.3748/wjg.v9.i5.1003
Published online May 15, 2003. doi: 10.3748/wjg.v9.i5.1003
Table 1 Characteristics of chronic hepatitis C patients treated with IFN-α
| Responders | Non responders | |
| Number | 13 | 7 |
| Age (Yr) | 41 | 40 |
| Sex (F/M) | 5/8 | 2/5 |
| Known duration of infection (Yr) | 10.6 | 9.9 |
| Baseline ALT (IU/ml) | 185 | 126 (P = 0.1660) |
| Baseline viral load (copies/ml) | 4.37 × 106 | 2.92 × 106 (P = 0.6908) |
Table 2 The serum reactive rates of chronic hepatitis C patients with the four HVR1 fusion proteins before IFN therapy
| Proteins | Responders (13) | Non responders (7) | Total (20) |
| SH1b | 69.2% (9/13) | 85.7% (6/7) | 75% (15/20) |
| BJ1b | 53.8% (7/13) | 57.1% (4/7) | 55% (11/20) |
| SD1b | 30.8% (4/13) | 71.4% (5/7) | 45% (9/20) |
| SD2a | 69.2% (9/13) | 71.4% (5/7) | 70% (14/20) |
| MIX | 69.2% (9/13) | 71.4% (5/7) | 70% (14/20) |
- Citation: Zhang XX, Zhang SY, Liu J, Lu ZM, Wang Y. Expression of hepatitis C virus hypervariable region 1 and its clinical significance. World J Gastroenterol 2003; 9(5): 1003-1007
- URL: https://www.wjgnet.com/1007-9327/full/v9/i5/1003.htm
- DOI: https://dx.doi.org/10.3748/wjg.v9.i5.1003